Dr. Shreya Shah , MD
Physician β’ Berkeley, CA
2001 Dwight Way, Alta Bates Cancer Center
Berkeley, CA 94704
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on July 26, 2007; this date does not establish years in practice.
-
Published CMS data list 1,473 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Abiraterone Acetate β 196 prescription fills, including refills.
- Prednisone β 162 prescription fills, including refills.
- Xtandi (Enzalutamide) β 135 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 32 records in the table Β· Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 1,112 in 2020 to 1,473 in 2024.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2020β2024.
Practice Location & Contact Primary Location
2001 Dwight Way
Alta Bates Cancer Center
Berkeley, CA 94704
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Permanente Medical Group Inc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
University Of Southern California Keck School Of Medicine
2004
What Public CMS Data Show
Physician: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
2,511 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$7,545,177 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2024.
Open Payments general payments, program year 2019
All general payments: $76.95 across 2 records.
By nature of payment
- Food and Beverage: $76.95 across 2 records.
Reporting-company totals
- Sirtex Medical Inc: $76.95 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2019 (published June 30, 2026).
Years since graduation
22 years (graduated 2004)
CMS Doctors and Clinicians data list 2004 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2007
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, βDoes your provider accept Medicare as full payment?β
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Shah has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Shah as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 32% from 1,112 in 2020 to 1,473 in 2024.
- 2020: 1,112
- 2021: 1,235
- 2022: 1,349
- 2023: 1,540
- 2024: 1,473
-
30-day fills
30-day fills increased 47% from 1,710 in 2020 to 2,511 in 2024.
- 2020: 1,710
- 2021: 1,851
- 2022: 2,235
- 2023: 2,564
- 2024: 2,511
-
Part D drug cost
Part D drug cost increased 65% from $4,573,109 in 2020 to $7,545,177 in 2024.
- 2020: $4,573,109
- 2021: $4,443,477
- 2022: $4,349,963
- 2023: $6,245,197
- 2024: $7,545,177
-
Industry payments (Open Payments)
CMS data for industry payments (Open Payments) are available for 2019 only.
Sources: CMS Medicare Part D Prescribers (2024), CMS Open Payments (2019), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2019 (payments made January 1 β December 31, 2019): fewer than 11 records totaling $76.95.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Sirtex Medical Inc |
Food and Beverage
Cash or cash equivalent
|
SIR-Spheres Microspheres | General | $65.72 |
| Sirtex Medical Inc |
Food and Beverage
Cash or cash equivalent
|
SIR-Spheres Microspheres | General | $11.23 |
Source: CMS Open Payments, program year 2019, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Abiraterone Acetate | Abiraterone Acetate | 196 | 12,014 | $55,923.66 | 44 |
| Prednisone | Prednisone | 162 | 13,016 | $1,510.19 | 54 |
| Xtandi | Enzalutamide | 135 | 4,028 | $1,603,002.97 | 17 |
| Tagrisso | Osimertinib Mesylate | 128 | 3,743 | $2,189,352.53 | 17 |
| Ondansetron Hcl | Ondansetron Hcl | 89 | 1,410 | $835.42 | 42 |
| Bicalutamide | Bicalutamide | 74 | 6,550 | $5,143.53 | 33 |
| Anastrozole | Anastrozole | 68 | 6,160 | $1,915.52 | 25 |
| Ibrance | Palbociclib | 63 | 1,535 | $972,248.68 | β |
| Dexamethasone | Dexamethasone | 56 | 950 | $877.39 | 28 |
| Megestrol Acetate | Megestrol Acetate | 36 | 1,008 | $2,369.73 | 19 |
| Potassium Chloride | Potassium Chloride | 35 | 2,403 | $1,303.88 | 13 |
| Alendronate Sodium | Alendronate Sodium | 34 | 2,829 | $333.19 | 11 |
| Lynparza | Olaparib | 34 | 1,030 | $531,391.05 | β |
| Lenvima | Lenvatinib Mesylate | 29 | 870 | $608,712.30 | β |
| Jakafi | Ruxolitinib Phosphate | 28 | 840 | $328,493.05 | β |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 26 | 229 | $398.88 | 19 |
| Levothyroxine Sodium | Levothyroxine Sodium | 25 | 1,820 | $373.36 | β |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 23 | 539 | $329.68 | β |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 22 | 432 | $601.37 | 15 |
| Inlyta | Axitinib | 22 | 600 | $264,728.37 | β |
| Lumakras | Sotorasib | 22 | 660 | $289,552.67 | β |
| Xarelto | Rivaroxaban | 21 | 1,032 | $16,343.83 | β |
| Gabapentin | Gabapentin | 19 | 1,763 | $380.23 | β |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 19 | 124 | $179.95 | β |
| Imatinib Mesylate | Imatinib Mesylate | 17 | 1,200 | $1,834.89 | β |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 282N00000X
An acute general hospital is an institution whose primary function is to provide inpatient diagnostic and therapeutic services for a variety of medical conditions, both surgical and non-surgical, to a wide population group. The hospital treats patients in an acute phase of illness or injury, characterized by a single episode or a fairly short duration, from which the patient returns to his or her normal or previous level of activity.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - MEDICAL ONCOLOGY
I20100915001038
CA
1052436946
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Permanente Medical Group Inc
7373 W Lane, Stockton, CA 952103377
Phone: 2094762000
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Psychiatry & Neurology - Psychiatry
Doctor of Medicine (M.D.)
Internal Medicine - Hematology & Oncology
Doctor of Medicine (M.D.)
Internal Medicine
Doctor of Medicine (M.D.)
Midwife
Certified Nurse Midwife, Nurse Practitioner, Master of Science
Physical Medicine & Rehabilitation
Doctor of Medicine (M.D.)
Psychiatry & Neurology - Child & Adolescent Psychiatry
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated July 26, 2007.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Mailing Address
1495 Valencia St Apt 1
San Francisco, CA 941106432
Phone: 3233145489